Literature DB >> 18160433

NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.

Kevin B Walsh1, Lewis L Lanier, Thomas E Lane.   

Abstract

Inoculation with the neurotropic JHM strain of mouse hepatitis virus (JHMV) into the central nervous system (CNS) of mice results in an acute encephalitis associated with an immune-mediated demyelinating disease. During acute disease, infiltrating CD8(+) T cells secrete gamma interferon (IFN-gamma) that controls replication in oligodendrocytes, while infected astrocytes and microglia are susceptible to perforin-mediated lysis. The present study was undertaken to reveal the functional contributions of the activating NKG2D receptor in host defense and disease following JHMV infection. NKG2D ligands RAE-1, MULT1, and H60 were expressed within the CNS following JHMV infection. The immunophenotyping of infiltrating cells revealed that NKG2D was expressed on approximately 90% of infiltrating CD8(+) T cells during acute and chronic disease. Blocking NKG2D following JHMV infection resulted in increased mortality that correlated with increased viral titers within the CNS. Anti-NKG2D treatment did not alter T-cell infiltration into the CNS or the generation of virus-specific CD8(+) T cells, and the expression of IFN-gamma was not affected. However, cytotoxic T-lymphocyte (CTL) activity was dependent on NKG2D expression, because anti-NKG2D treatment resulted in a dramatic reduction in lytic activity by virus-specific CD8(+) T cells. Blocking NKG2D during chronic disease did not affect either T-cell or macrophage infiltration or the severity of demyelination, indicating that NKG2D does not contribute to virus-induced demyelination. These findings demonstrate a functional role for NKG2D in host defense during acute viral encephalitis by selectively enhancing CTL activity by infiltrating virus-specific CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160433      PMCID: PMC2259000          DOI: 10.1128/JVI.02033-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  94 in total

1.  The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa.

Authors:  Michael T Borchers; Nathaniel L Harris; Scott C Wesselkamper; Shiping Zhang; Yi Chen; Lisa Young; Gee W Lau
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.

Authors:  Cristina Cerboni; Francesca Neri; Nicoletta Casartelli; Alessandra Zingoni; David Cosman; Paolo Rossi; Angela Santoni; Margherita Doria
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.

Authors:  Kouetsu Ogasawara; Jonathan Benjamin; Rayna Takaki; Joseph H Phillips; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-08-07       Impact factor: 25.606

4.  Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.

Authors:  Stine Kjellev; Claus Haase; Dorthe Lundsgaard; Birgitte Ursø; Ditte Tornehave; Helle Markholst
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

5.  NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.

Authors:  Philippe Saikali; Jack P Antel; Jia Newcombe; Zhihong Chen; Mark Freedman; Manon Blain; Romain Cayrol; Alexandre Prat; Jeffery A Hall; Nathalie Arbour
Journal:  J Neurosci       Date:  2007-01-31       Impact factor: 6.167

6.  Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells.

Authors:  Alexandra Rausch; Manuela Hessmann; Alexandra Hölscher; Tanja Schreiber; Silvia Bulfone-Paus; Stefan Ehlers; Christoph Hölscher
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.

Authors:  John M González; Cornelia C Bergmann; Chandran Ramakrishna; David R Hinton; Roscoe Atkinson; Jason Hoskin; Wendy B Macklin; Stephen A Stohlman
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

8.  The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.

Authors:  Tihana Lenac; Matthias Budt; Jurica Arapovic; Milena Hasan; Albert Zimmermann; Hrvoje Simic; Astrid Krmpotic; Martin Messerle; Zsolt Ruzsics; Ulrich H Koszinowski; Hartmut Hengel; Stipan Jonjic
Journal:  J Exp Med       Date:  2006-07-10       Impact factor: 14.307

Review 9.  Coronavirus infection of the central nervous system: host-virus stand-off.

Authors:  Cornelia C Bergmann; Thomas E Lane; Stephen A Stohlman
Journal:  Nat Rev Microbiol       Date:  2006-02       Impact factor: 60.633

10.  Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells.

Authors:  Jun Zuo; Stephen A Stohlman; Jason B Hoskin; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

View more
  19 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 3.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.

Authors:  Carine Savarin; Cornelia C Bergmann
Journal:  Curr Opin Pharmacol       Date:  2008-06-16       Impact factor: 5.547

5.  Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection.

Authors:  Kevin B Walsh; David Marsolais; Megan J Welch; Hugh Rosen; Michael B A Oldstone
Journal:  Virology       Date:  2009-12-03       Impact factor: 3.616

6.  CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination.

Authors:  Martin P Hosking; Emanuele Tirotta; Richard M Ransohoff; Thomas E Lane
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

7.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

8.  MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination.

Authors:  Jason G Weinger; Brian M Weist; Warren C Plaisted; Suzi M Klaus; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

9.  Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Authors:  Jason G Weinger; Warren C Plaisted; Sonia M Maciejewski; Lewis L Lanier; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

10.  A protective role for ELR+ chemokines during acute viral encephalomyelitis.

Authors:  Martin P Hosking; Liping Liu; Richard M Ransohoff; Thomas E Lane
Journal:  PLoS Pathog       Date:  2009-11-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.